McFarland HF - Search Results

1

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R. Bielekova B, et al. Among authors: mcfarland hf. Arch Neurol. 2009 Apr;66(4):483-9. doi: 10.1001/archneurol.2009.50. Arch Neurol. 2009. PMID: 19364933 Free PMC article. Clinical Trial.

2

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation.

Racke MK, Martin R, McFarland H, Fritz RB. Racke MK, et al. J Neuroimmunol. 1992 Mar;37(1-2):75-84. doi: 10.1016/0165-5728(92)90157-g. J Neuroimmunol. 1992. PMID: 1372332

3

A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.

Vergelli M, Le H, van Noort JM, Dhib-Jalbut S, McFarland H, Martin R. Vergelli M, et al. J Immunol. 1996 Jul 15;157(2):679-88. J Immunol. 1996. PMID: 8752917

4

Experimental immunotherapies for multiple sclerosis.

Martin R, McFarland H. Martin R, et al. Springer Semin Immunopathol. 1996;18(1):1-24. doi: 10.1007/BF00792605. Springer Semin Immunopathol. 1996. PMID: 8984675 Free PMC article. Review.

5

Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.

Vergelli M, Hemmer B, Kalbus M, Vogt AB, Ling N, Conlon P, Coligan JE, McFarland H, Martin R. Vergelli M, et al. J Immunol. 1997 Apr 15;158(8):3746-52. J Immunol. 1997. PMID: 9103439

6

Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trials.

Tresley RM, Stone LA, Fields N, Maloni H, McFarland H, Frank JA. Tresley RM, et al. Neurology. 1997 Apr;48(4):832-5. doi: 10.1212/wnl.48.4.832. Neurology. 1997. PMID: 9109864

7

Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.

Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, Wiesmüller KH. Hemmer B, et al. J Exp Med. 1997 May 5;185(9):1651-9. doi: 10.1084/jem.185.9.1651. J Exp Med. 1997. PMID: 9151902 Free PMC article.

8

T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors.

Mazzanti B, Vergelli M, Riccio P, Martin R, McFarland HF, Liuzzi GM, Amaducci L, Massacesi L. Mazzanti B, et al. Among authors: mcfarland hf. J Neuroimmunol. 1998 Feb;82(1):96-100. doi: 10.1016/S0165-5728(97)00194-X. J Neuroimmunol. 1998. PMID: 9526851

9

Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases.

Bielekova B, Lincoln A, McFarland H, Martin R. Bielekova B, et al. J Immunol. 2000 Jan 15;164(2):1117-24. doi: 10.4049/jimmunol.164.2.1117. J Immunol. 2000. PMID: 10623864

10

Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study.

Bagnato F, Tancredi A, Richert N, Gasperini C, Bastianello S, Bash C, McFarland H, Pozzilli C, Frank JA. Bagnato F, et al. Mult Scler. 2000 Feb;6(1):43-9. doi: 10.1177/135245850000600109. Mult Scler. 2000. PMID: 10694845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters